MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

EDT MEI Pharma (MEIP) files to sell 25.3M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, ...

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

This strategic move, developed in partnership with GSR and with guidance provided by Litecoin Creator and MEI Board member Charlie Lee, marks the beginning of MEI’s broader institutional treasury ...

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

With half-year industry financings down 59% from last year, and a U.S. administration supportive of cryptocurrencies, ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging with institutional interest and ...

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP) (“MEI”), in which it will serve as both strategic advisor and digital ...

MEI Pharma's portfolio of drug candidates contains four clinical-stage assets, including zandelisib, currently in an ongoing Phase 2 clinical trial which may support an accelerated approval ...

MEI Pharma is back at support levels where there has been significant buying interest - including a large private placement in 2018 that stoked a rally. The MEI Pharma pipeline is progressing well ...